Alejandro Schcolnik‐Cabrera

1.1k total citations
34 papers, 780 citations indexed

About

Alejandro Schcolnik‐Cabrera is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Alejandro Schcolnik‐Cabrera has authored 34 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Alejandro Schcolnik‐Cabrera's work include Cancer, Hypoxia, and Metabolism (8 papers), Cancer, Lipids, and Metabolism (6 papers) and Mycobacterium research and diagnosis (4 papers). Alejandro Schcolnik‐Cabrera is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Cancer, Lipids, and Metabolism (6 papers) and Mycobacterium research and diagnosis (4 papers). Alejandro Schcolnik‐Cabrera collaborates with scholars based in Mexico, Canada and United States. Alejandro Schcolnik‐Cabrera's co-authors include Alfonso Dueñas‐González, Mandy Juárez, Guadalupe Domínguez-Gómez, Alma Chávez‐Blanco, Mayra Cruz‐Rivera, Ana Flisser, Fela Mendlovic, Bernardo Oldak, Rocío Morales‐Bárcenas and Aurora González‐Fierro and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Life Sciences.

In The Last Decade

Alejandro Schcolnik‐Cabrera

33 papers receiving 769 citations

Peers

Alejandro Schcolnik‐Cabrera
Duo‐Yao Cao United States
Alejandro Schcolnik‐Cabrera
Citations per year, relative to Alejandro Schcolnik‐Cabrera Alejandro Schcolnik‐Cabrera (= 1×) peers Duo‐Yao Cao

Countries citing papers authored by Alejandro Schcolnik‐Cabrera

Since Specialization
Citations

This map shows the geographic impact of Alejandro Schcolnik‐Cabrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Schcolnik‐Cabrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Schcolnik‐Cabrera more than expected).

Fields of papers citing papers by Alejandro Schcolnik‐Cabrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Schcolnik‐Cabrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Schcolnik‐Cabrera. The network helps show where Alejandro Schcolnik‐Cabrera may publish in the future.

Co-authorship network of co-authors of Alejandro Schcolnik‐Cabrera

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Schcolnik‐Cabrera. A scholar is included among the top collaborators of Alejandro Schcolnik‐Cabrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Schcolnik‐Cabrera. Alejandro Schcolnik‐Cabrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schcolnik‐Cabrera, Alejandro, Rommel Chacón‐Salinas, Rocío Morales‐Bárcenas, et al.. (2025). Epigenetic reprogramming of mast and cancer cells modifies tumor-promoting cytokine networks. Medical Oncology. 42(9). 371–371.
2.
Basso, Paulo José, et al.. (2025). Weight Loss‐Associated Remodeling of Adipose Tissue Immunometabolism. Obesity Reviews. 26(12). e13975–e13975. 1 indexed citations
3.
Schcolnik‐Cabrera, Alejandro, et al.. (2024). Glioblastoma stem cell metabolism and immunity. Cancer and Metastasis Reviews. 43(3). 1015–1035. 10 indexed citations
4.
Issa, Mark E., et al.. (2023). Similarities and divergences in the metabolism of immune cells in cancer and helminthic infections. Frontiers in Oncology. 13. 1251355–1251355. 3 indexed citations
5.
Corzo, Gerardo, et al.. (2022). The Resilience of Pseudomonas aeruginosa to Antibiotics and theDesigning of Antimicrobial Peptides to Overcome Microbial Resistance. Current Medicinal Chemistry. 30(1). 72–103. 4 indexed citations
6.
Galicia-Vázquez, Gabriela, Alejandro Schcolnik‐Cabrera, Vincent Luo, et al.. (2022). EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax. Journal of Experimental & Clinical Cancer Research. 41(1). 340–340. 13 indexed citations
7.
Schcolnik‐Cabrera, Alejandro, et al.. (2022). Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer. Cellular Oncology. 45(5). 831–859. 14 indexed citations
8.
Vargas‐Morales, Juan Manuel, Berenice Palacios‐González, Alejandro Schcolnik‐Cabrera, et al.. (2021). Association of BCAT2 and BCKDH polymorphisms with clinical, anthropometric and biochemical parameters in young adults. Nutrition Metabolism and Cardiovascular Diseases. 31(11). 3210–3218. 4 indexed citations
9.
Schcolnik‐Cabrera, Alejandro, Alma Chávez‐Blanco, Guadalupe Domínguez-Gómez, et al.. (2021). Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy. Scientific Reports. 11(1). 5222–5222. 16 indexed citations
10.
Juárez, Mandy, Alejandro Schcolnik‐Cabrera, Guadalupe Domínguez-Gómez, et al.. (2020). Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug. Cancer Chemotherapy and Pharmacology. 85(6). 1153–1163. 29 indexed citations
11.
Schcolnik‐Cabrera, Alejandro, et al.. (2020). Perspectives on Drug Repurposing. Current Medicinal Chemistry. 28(11). 2085–2099. 27 indexed citations
12.
Schcolnik‐Cabrera, Alejandro, Mandy Juárez, Bernardo Oldak, et al.. (2020). In Vitro Employment of Recombinant Taenia solium Calreticulin as a Novel Strategy Against Breast and Ovarian Cancer Stem-like Cells. Archives of Medical Research. 51(1). 65–75. 12 indexed citations
13.
Schcolnik‐Cabrera, Alejandro, et al.. (2020). Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments. Archives of Medical Research. 52(3). 243–251. 28 indexed citations
14.
Vargas‐Castillo, Ariana, Leonardo del Valle‐Mondragón, Iván Torre-Villalvazo, et al.. (2019). Angiotensin-(1-7) induces beige fat thermogenesis through the Mas receptor. Metabolism. 103. 154048–154048. 25 indexed citations
15.
Schcolnik‐Cabrera, Alejandro, Bernardo Oldak, Mandy Juárez, et al.. (2019). Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes. APOPTOSIS. 24(3-4). 245–255. 81 indexed citations
17.
Schcolnik‐Cabrera, Alejandro, et al.. (2016). TLR4 and DC-SIGN receptors recognized Mycobacterium scrofulaceum promoting semi-activated phenotype on bone marrow dendritic cells. Tuberculosis. 99. 31–40. 5 indexed citations
18.
Carrillo‐Casas, Erika M., Roberto Arenas, Sonia Toussaint, et al.. (2015). Mucormycosis in a Non-Hodgkin Lymphoma Patient Caused by Syncephalastrum racemosum: Case Report and Review of Literature. Mycopathologia. 180(1-2). 89–93. 12 indexed citations
19.
Schcolnik‐Cabrera, Alejandro, et al.. (2014). Lipotransferencia complicada con micobacteriosis atípicas. Reporte de dos casos y revisión de la literatura. Gaceta Médica de México. 150(3). 311–316. 1 indexed citations
20.
Schcolnik‐Cabrera, Alejandro, et al.. (2014). Reduced-intensity stem cell allografting for PNH patients in the eculizumab era: The Mexican experience. Hematology. 20(5). 263–266. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026